What is a combination treatment and how it may be used in onychomycosis
- Authors: Sergeev Y.V1, Sergeev VY.1, SERGEEV YV1, SERGEEV AY1
-
Affiliations:
- Issue: Vol 87, No 5 (2011)
- Pages: 125-130
- Section: Articles
- Submitted: 11.03.2020
- Published: 15.10.2011
- URL: https://vestnikdv.ru/jour/article/view/1080
- DOI: https://doi.org/10.25208/vdv1080
- ID: 1080
Cite item
Full Text
Abstract
Combination treatment of onychomycosis is based on supplementation of systemic antifungal therapy with different
topical techniques, which now include antifungal nail lacquers. Controversies in establishing potential and efficacy of
combination treatment in onychomycosis may be overcome by rational administration of any treatment modality after
careful evaluation of both the disease and the patient. Application of antifungal nail varnishes such as 8% ciclopirox
offers several benefits in treating onychomycosis. With improved efficacy and safety, onychomycosis combination
therapy appears to be less expensive and more reliable in terms of reduced rates of relapse and re-infection. Russian
and international clinical trials and studies with ciclopirox nail lacquer have revealed the indications and proved the high
effectiveness of certain algorithms of combination treatment.
topical techniques, which now include antifungal nail lacquers. Controversies in establishing potential and efficacy of
combination treatment in onychomycosis may be overcome by rational administration of any treatment modality after
careful evaluation of both the disease and the patient. Application of antifungal nail varnishes such as 8% ciclopirox
offers several benefits in treating onychomycosis. With improved efficacy and safety, onychomycosis combination
therapy appears to be less expensive and more reliable in terms of reduced rates of relapse and re-infection. Russian
and international clinical trials and studies with ciclopirox nail lacquer have revealed the indications and proved the high
effectiveness of certain algorithms of combination treatment.
References
- Baran R., Hay R.J. New evidence for the efficacy of combination therapy in onychomycosis. Br J Dermatol 2001; 145 (60):1.
- Evans E.G. The rationale for combination therapy. Br J Dermatol. 2001; 145 (60): 9-13.
- Hay R.J. The future of onychomycosis therapy may involve a combination of approaches. Br J Dermatol 2001; 145 (60): 3-8.
- Gupta A.K., Lynde C.W., Konnikov N. Singleblind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001; 44 (3): 485-91.
- Сергеев А.Ю. Индекс для клинической оценки онихомикоза и расчета продолжительности терапии системными антимикотиками. М. 1999; 44 С.
- Polak-Wyss A. Mechanism of action of antifungals and combination therapy. J Eur Acad Dermatol 1995; 4 (1): 11-6.
- Сергеев Ю.В., Шпигель Б.И., Сергеев А.Ю. Фармакотерапия микозов. М: Медицина для всех. 2003; 200 с.
- Сергеев А.Ю., Сергеев Ю.В., Лысенко В.И., Тарасова М.О. Онихомикозы: принципы и практика комбинированной терапии. Журн. дерматовенерол. и косметол. 2002; 1: 5-7.
- Сергеев А.Ю. Грибковые заболевания ногтей. М: Национальная академия микологии - Медицина для всех. 2001; 164 с.
- Баранов А.Ф., Конопихина Т.А., Углова С.В. Комбинированное лечение онихомикозов гризеофульвином в сочетании с местной те- рапией. Вестн. дерматол. и венерол. 1966; 40 (1): 46-9.
- Колоколова Н.В., Фролова Н.О. Опыт терапии онихомикоза гризеофульвином в сочетании с наружными противотивогрибковыми сред- ствами. Сов. мед. 1967; 30 (9): 141-2.
- Zaias N., Battistini F., Gomez-Urcuyo F. et al. Treatment of «tinea pedis» with griseofulvin and topical antifungal cream. Cutis 1978; 22 (2): 197-9.
- Сергеев Ю.В., Сергеев А.Ю. Онихомикозы: грибковые инфекции ногтей. М.: Гэотар 1998; 150.
- Olafsson J.H., Sigurgeirsson B., Baran R. Combination therapy for onychomycosis. Br J Dermatol 2003; 149 (65): 15-8.
- Gupta A.K., Ryder J.E. How to improve cure rates for the management of onychomycosis. Dermatol Clin. 2003; 21 (3):499-505.
- Gupta A.K., Baran R., Summerbell R. Onychomycosis: strategies to improve efficacy and reduce recurrence. J Eur Acad Dermatol Venereol 2002; 16 (6): 579-86.
- Сергеев А.Ю. Вопросы фармакокинетики и эффективность системной терапии онихомикозов. Иммунопатол. аллергол. инфектол. 2000; 2: 88-96.
- Сергеев А.Ю., Иванов О.Л., Сергеев Ю.В. и др. Эффективность системной терапии онихомикозов: отдаленные результаты и рециди- вы. Иммунопатол. аллергол. инфектол. 2001; 1: 102-6.
- Seebacher C. Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. Mycoses 2003; 46 (11-12): 506-10.
- Сергеев А.Ю., Иванов О.Л., Сергеев Ю.В. и др. Исследование современной эпидемиологии онихомикоза. Вестн. дерматол. венерол. 2002; 3: 31-5.
- Сергеев А.Ю., Сергеев Ю.В. Чему учат клини- циста исследования эпидемиологии дерматомикозов? Успехи медицинской микологии. М.: Национальная академия микологии, ма- териалы Первого всероссийского конгресса по медицинской микологии. 2003; 2: 154.
- Местная и комбинированная терапия онихомикозов. Пособие для врачей (под редакцией Ю.В. Сергеева) М.: 2003; 32.
- Sergeev Y.V., Vladimirov V.V. Вatrafen (ciclopyrox) 8% nail lacquer in treatment of different forms of onychomycosis. Abstracts of the V congress of EADV, Lisbon 1996.
- Gupta A.K. Mycologic Response to Terbinafine Treatment of Severe Onychomycosis with or without Ciclopirox Nail Lacquer Interim Results. American Academy of Dermatology 2003 meeting Poster session. Abstract p438. P. 156.
- Seebacher C., Nietsch K.H., Ulbricht H.M. A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes. Cutis 2001; 68 (2 Suppl): 17-22.
- Gupta A.K., Fleckman P., Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol 2000; 43 (4): 70-80.
- Gupta A. K. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. J Am Acad Dermatol 2000; 43 (4): 81-95.
- Einarson T. R. Pharmacoeconomic applications of meta-analysis for single groups using antifungal onychomycosis lacquers as an example. Clin Ther 1997; 19 (3): 559-69; discussion 38-39.
- Tosti A., Piraccini B. M., Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000; 42 (2 Pt 1): 217-24.
- Ulbricht H., Worz K. Therapy with ciclopirox lacquer of onychomycoses caused by molds. Mycoses 1994; 37 (1): 97-100.
- Omar M., Kahler K., Doug G. Persistency of Terbinafine versus Ciclopirox Solution 8% in Patients with Toenail Onychomycosis. American Academy of Dermatology 2003 meeting Poster session. Abstract p399. P 143-144.
- Verkh F., Getsie M., Chern W. Ciclopirox 8% Nail Lacquer: How Many Applications Are in a 3.3-ML Bottle? American Academy of Dermatology 2003 meeting Poster session. Abstract p407. P 146. Литература